Current stock page

Catalysts

VOR Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

VORVor Biopharma Inc.

Healthcare / Biotechnology

Leader

Sector Leader

BullishEdge 10/10
$19.42+$0.10 (+0.52%)

Latest quote

  • Momentum
    72
  • Value
    —
  • Quality
    69
  • Risk resilience
    46
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
—

No upcoming reporting date is available yet.

AIQ Catalyst
AIQ 66/100

Momentum 72/100 and sentiment — before the next covered event.

Recent coverage
3 articles

Updated Nov 15, 2026 · Sentiment 43.85%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 72/100AIQ Edge 10/10 Sector Leader
Beat rate
25%
2 of 8 reported periods
Average surprise
-570.8%
Across covered historical reports
Latest result
-34.3%
Oct 30, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Oct 30, 2026—-$1.08-$1.45-34.3%——
Aug 11, 2026—-$0.69-$1.16-68.1%——
May 13, 2026—-$0.75-$0.73+2.7%——
Mar 30, 2026—-$1.14$44.50+4003.5%——
Nov 13, 2025—-$3.06-$121.63-3874.8%——
Aug 12, 2025—-$11.40-$251.20-2103.5%——
May 15, 2025—-$5.00-$5.20-4.0%——
Mar 20, 2025—-$0.34-$8.80-2488.2%——

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
9
Buy
1
Hold
12-month analyst target
$40.00
+105.97% versus current price
Based on 10 analyst observations. Targets are estimates, not predictions.
Low target
$40.00
+105.97% vs latest price
Average target
$40.00
+105.97% vs latest price
High target
$40.00
+105.97% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event date—

Upcoming earnings date not available yet.

Sentiment score—

News pressure around the setup.

Momentum score72

Where event reaction would show up first.

AIQ score66/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
10
Average target
$40.00
Target upside
105.97%
Target range
$40.00 - $40.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
3
Neutral
0
Negative
0
gurufocus.com · Nov 12, 2026

Vor Biopharma (VOR) Expands RC298 Licensing Deal with RemeGen, Valued up to $356M

On November 12, 2026, Vor Biopharma Inc (NASDAQ: VOR) announced a modification to its collaboration agreement with RemeGen (OTC: REGMF) to include the next-gene

seekingalpha.com · Sep 18, 2026

Vor Biopharma: A Funded Replication Story With Franchise Potential (NASDAQ:VOR)

Vor Biopharma is advancing telitacicept globally, leveraging strong Chinese clinical evidence and a robust liquidity position. Read why VOR stock is a buy.

seekingalpha.com · Sep 9, 2026

Vor Biopharma Inc. (VOR) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Vor Biopharma Inc. (VOR) Citigroup's Biopharma Back to School Summit 2026 September 9, 2026 11:20 AM EDTCompany ParticipantsJean-Paul Kress - Chairman,...

Open full news and sentiment

VOR Catalysts FAQ

What are the next catalysts for VOR stock?

VOR's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move VOR stock?

Upcoming events that could move VOR include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could VOR's next earnings report affect the stock?

VOR's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive VOR stock higher?

VOR could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt VOR stock?

VOR could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.